Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BMY - Better Buy: Geron vs. Celgene


BMY - Better Buy: Geron vs. Celgene

For the most part, biotech stocks aren't having a great year with only a little over two months left in 2019. The top biotech-focused exchange-traded funds (ETFs) are trailing the S&P 500 year to date. But Geron (NASDAQ: GERN) and Celgene (NASDAQ: CELG) are sizzling hot, with the stocks soaring 43% and 61%, respectively, so far this year.

Which of these two high-flying biotech stocks is the better pick for long-term investors? Here's how Geron and Celgene compare. 

Image source: Getty Images.

Continue reading

Stock Information

Company Name: Bristol-Myers Squibb Company
Stock Symbol: BMY
Market: NYSE
Website: bms.com

Menu

BMY BMY Quote BMY Short BMY News BMY Articles BMY Message Board
Get BMY Alerts

News, Short Squeeze, Breakout and More Instantly...